21 May 2025
Management of non-culprit lesions in patients with ACS and multivessel disease
With the collaboration of the Cardiovascular Intervention Association of Thailand (CIAT) and Korean Society of Interventional Cardiology
Anchorpersons:
Y. Ahn, M. Chandavimol
Discussants:
P. K. Min, N. Sansanayudh
Summary
This session addresses the optimal management of non-culprit lesions (NCL) in patients with acute coronary syndrome (ACS) and multivessel disease. Learn about angiography, imaging, and FFR-guided strategies, timing considerations for PCI in high-risk NSTEMI patients, and patient selection for early staged PCI post-STEMI through detailed case discussions.
Learning Objectives
- To consider for better treatment: angiography, imaging, or FFR-guided approaches for managing non-culprit lesions in patients with ACS and multivessel disease
- To determine the optimal timing for PCI (immediate vs. staged) of NCLs in high-risk NSTEMI patients with multivessel disease
- To identify patients for whom very early staged PCI post STEMI may not represent the safest treatment option
